Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
22 Leser
Artikel bewerten:
(0)

CB&I and Clariant's Polypropylene Catalyst Partnership off to a Successful Start

THE WOODLANDS, Texas, July 22, 2014 /PRNewswire/ --CB&I (NYSE:CBI) and Clariant announced today its new Ziegler-Natta (ZN) polypropylene catalyst production plant in Louisville, Kentucky, is on schedule to begin production in 2015. The plant is part of a long-term strategic partnership between Clariant's Catalysts business unit and CB&I's Lummus Novolen Technology business. Based at Clariant's largest US production hub, the state-of-the-art facility will combine innovative catalysts - jointly developed by both companies with high-capacity output to serve the fast growing polypropylene industry.

The partnership strengthens both companies' position in polypropylene catalyst and technology by leveraging Clariant's catalyst research and development and production know-how together with CB&I's vast knowledge in catalyst, process design and licensing of polypropylene plants.

As a result of the intensive joint efforts from research and development teams of Clariant and CB&I, a series of new ZN polypropylene catalysts to be produced in the Louisville plant has been developed recently. The PolyMax and NHP (Novolen High Performance) catalyst series with merged and improved technical and commercial features from both Clariant's and CB&I's research and development pipelines is a drop-in catalyst based on a 'one-for-all' solution. Both series are currently being tested in several commercial polypropylene plants demonstrating outstanding performance.

The strategic partnership with a major polypropylene process licensor like CB&I marks a new era for the polypropylene catalyst segment within Clariant. Stefan Heuser, Senior Vice President, Head of BU Catalysts Clariant, states: "The successful joint development of new generation polypropylene catalyst and progressing of Louisville plant are key milestones for our catalyst business. It strengthens greatly our competitive position in this attractive and fast growing market."

"Polypropylene producers will benefit from this joint catalyst development effort. High productivity, versatility and quality consistency will be the major benefits coupled with competitive economics," says Daniel McCarthy, President of CB&I's Technology operating group. "We are very pleased with the progress made with the Clariant team in all the areas of our joint effort. Our commitment is to continue to bring value to our clients and owners."

About Clariant
Clariant (www.clariant.com) is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On December 31, 2012 the company employed a total workforce of 21,202. In the financial year 2012, Clariant recorded sales of CHF 6.038 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis & Energy, Natural Resources, and Plastics & Coatings. Clariant's corporate strategy is based on four pillars: managing businesses for profitability, research & development and innovation, growth in emerging markets, and repositioning of the portfolio.

About CB&I
CB&I (NYSE:CBI) is the most complete energy infrastructure focused company in the world and a major provider of government services. With 125 years of experience and the expertise of approximately 55,000 employees, CB&I provides reliable solutions while maintaining a relentless focus on safety and an uncompromising standard of quality. For more information, visit www.cbi.com.

Important Information For Investors And Shareholders

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements regarding CB&I and represents our expectations and beliefs concerning future events. These forward-looking statements are intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties. When considering any statements that are predictive in nature, depend upon or refer to future events or conditions, or use or contain words, terms, phrases or expressions such as "achieve," "forecast," "plan," "propose," "strategy," "envision," "hope," "will," "continue," "potential," "expect," "believe," "anticipate," "project," "estimate," "predict," "intend," "should," "could," "may," "might" or similar forward-looking statements, we refer you to the cautionary statements concerning risk factors and "Forward-Looking Statements" described under "Risk Factors" in Item 1A of our Annual Report filed on Form 10-K filed with the SEC for the year ended December 31, 2013, and any updates to those risk factors or "Forward-Looking Statements" included in our subsequent Quarterly Reports on Form 10-Q filed with the SEC, which cautionary statements are incorporated herein by reference.

For more information, visit www.cbi.com (http://www.cbi.com)
Clariant Logo

Logo - http://photos.prnewswire.com/prnh/20130430/DA04155LOGO
Logo - http://photos.prnewswire.com/prnh/20140721/129042

SOURCE CB&I

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.